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                                             ABSTRACT 
 
The  Aim of the study is to compare the changes in Brainstem Auditory Evoked Potential  
and Visual Evoked Potential  in VertebroBasilar  Transient Ischemic Attack  patients to 
the normal subject.   
For this study, Auditory Evoked Potential and visual evoked potential were recorded in 
40 patients with Vertebrobasilar  Transient Ischemic Attack  and  40 normal control 
group. This study was conducted at Research Laboratory , Department of 
Physiology,Thanjavur Medical College, Thanjavur. The Study group was from the 
Thanjavur Medical College  & Hospital, Thanjavur. 
 Exclusion criteria were mainly Stroke, other Neurological diseases or Hearing loss. 
Informed written consent from the patients of  Thanjavur Medical College  & Hospital  
and control group was obtained. 
                      In Brainstem Auditory Evoked Potential ,the Absolute Latency of Wave V 
was prolonged and amplitude reduction  was observed  in  Wave V of Vertebrobasilar 
Transient Ischemic Attack patient and was found to be statistically significant. 
          In Visual  Evoked Potential , no changes were observed in the Absolute Latency 
and  amplitude  of  Vertebrobasilar Transient Ischemic Attack patient and was found to 
be statistically insignificant. 
                                   
 
INTRODUCTION 
            Transient Ischemic Attack describes the symptoms of nervous system due to 
ischemic origin that lasts for less than 24 hours. Indeed  most of the attacks last 
only few minutes to an hour.
  (1) 
This transient attack is  based on more than one mechanism. If any  stenosis  is 
present in the vertebrobasilar system, Transient ischemia will be caused by 
reduction of blood distally.  The Transient ischaemia is mainly because of  
inadequate collateral bloodflow. VB TIA  may have a hemodynamic  basis which 
includes transient hypotension or cardiac arrhythmia.
 (1) 
     In clinical medicine Ischemia is the common form of cell injury which results 
from hypoxia that is induced by reduction in blood flow mostly it is due to 
mechanical obstruction of artery.
(2) 
So in ischemic tissues not only the aerobic metabolism is compromised, but also 
the energy generation by anaerobic metabolism stops having all glycolytic 
substances are exhausted. The  accumulated metabolites  will lead to inhibition of 
glycolysis.  The biochemically altered reactions occur following ischemia, which 
will be summarized  here. When the oxygen tension falls inside the cell, there will 
be loss of oxidative phosphorylation and the ATP generation will be decreased. 
This ATP depletion leads to sodium pump failure causes potassium efflux sodium 
and water efflux and eventually cell swelling. 
(2) 
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Influx of calcium also occurs which have many detrimental effects. Progressive  
loss of the glycogen, and reduction in protein synthesis occur. 
(2 )
 
Attacks may be  due to embolism from the heart or atherosclerotic plaque from the 
proximal large vessel. Because of the responsiveness of the TIA to calcium channel 
blockers, it suggests that the etiology is due to vasospasm. Lipohyalinosis and 
atherosclerotic plaques are  caused by long standing hypertension ,diabetes or other 
vascular risk factors.
 (1)
 
       It also  has been associated with anemia,hyperviscosity,polycythemia, 
 thrombocytosis, bacterial  endocarditis,cerebral venous thrombosis,and    
       it may clear with correction of the underlying disorder.
 (1)
 
TRANSIENT ISCHEMIC ATTACK: 
   It is an  indicator of stroke. Twenty to twenty five% of the Ischemic stroke is due 
to a defect in the vertebrobasilar arterial Circulation
.(3) 
It is a temporary Neurological deficit of sudden onset. The onset of symptoms in 
TIA is sudden and it reaches its maximum intensity immediately. If it had not 
follow a  complete clinical recovery, then it would not be a TIA. 
Following are the symptoms that confirm the typical TIA in the posterior 
Circulation System.
 (3) 
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1. Bilateral dysfunction of the motor or sensory system. 
    2 .Either Complete loss of vision or partial loss of vision in the homonymous 
field of both eyes. 
    3.  Vertigo, Diplopia, Dysphagia, Dysarthria and  Ataxia. 
To consider this as a TIA,  the above symptoms should be  present as an isolated  or 
two or more combination of the symptoms. 
Isolated  presence of the above symptoms won‟t be consider as TIA.(3) 
                    Changes of cerebral blood flow in VB TIA patients had studied by 
Drake ME  et al on the basis of brainstem auditory evoked potential and visual 
evoked potential by P  Benna et al.
 (4,5)
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AIMS AND OBJECTIVES 
 
This study was undertaken to compare the electrophysiological parameters between 
VB TIA patients and the control. 
 
To evaluate the changes in blood flow in VB TIA patients by doing the 
electrophysiological parameters like brainstem auditory evoked potential and visual 
evoked potential. 
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REVIEW OF LITERATURE 
CEREBROVASCULAR ANATOMY: 
VERTEBROBASILAR ARTERY: 
 
 
                                             FIGURE:1 
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The brain receives blood supply from two pairs of arteries ,the right and left 
internal carotid arteries .Two vertebral arteries combines to form basilar artery . 
The basilar artery supply  brainstem and posterior portion of  cerebral hemisphere . 
This artery and the two internal carotid arteries unite to form the circle of Willis.
 (7) 
CIRCLE OF WILLIS: 
 
                                                 FIGURE:2 
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SUBCLAVIAN ARTERY: 
The two vertebral arteries arise from the subclavian artery just proximal to the 
thyrocervical trunk in the neck.  This subclavian artery also gives the following 
branches . They are  internal thoracic artery, thyrocervicaltrunk,and costocervical 
trunk
. (7)
 
COURSE IN CERVICAL VERTEBRAE: 
It ascends and pass through the foramina of the transverse processes of the  cervical 
vertebrae and enter into the skull via the foramen magnum. There will be a 
variations in the level of entry of the vertebral artery into the foramina of cervical 
vertebrae.
  
This  left  subclavian artery  arises directly from the aorta while the left 
subclavian artery arises from the Brachio -cephalic trunk.
 (7) 
COURSES  IN THE BRAIN: 
 Then it course along the anterolateral surface of the medulla where it gives 
branches that supply the medulla and the inferior aspect of the cerebellum before it 
forms the basilar artery at the pontomedullary junction. 
  
The basilar artery occupy 
the anterior surface of the brainstem and supplies the pons ,cerebellum and 
midbrain. Then it bifurcates into two  posterior cerebral arteries which supply the 
postero-lateral aspect of midbrain,thalamus and occipital lobes.
(7)
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CORTICAL  VASCULAR TERRITORIES: 
 
 
                                          FIGURE:3 
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CAUSES OF CEREBRAL ISCHEMIA:
 (6) 
VASCULAR DISORDER: 
Atherosclerosis 
Migraine 
Connective tissue disorders 
Drugs (Sympathomimetics) 
Infective arteritis 
Sickle cell anemia vasculopathy 
Vascular dissection 
Vascular trauma 
Venous thrombosis 
Vasculitis 
Vasospasm  
 
SYSTEMIC EMBOLISM: 
Cardiac thrombus (Atrial Fibrillation, atrial myxoma, Dilated 
cardiomyopathy,Myocardial Infarction,Ventricular Aneurysm ) 
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Fat Embolism. 
Infective endocarditis  
Valvular Heart disease 
 
HAEMATOLOGICAL DISORDERS: 
Hypercoagulable states (Disseminated Intravascular Coagulation ,Paroxysmal 
Nocturnal Hemoglobinuria ,Thrombotic Thrombocytopenic Purpura) 
Hyperviscosity syndromes (PolyCythemiaVera , Myeloproliferative 
disorders,thrombocytosis) 
 
OTHERS: 
Nephritic Syndrome 
Oral contraceptive pills 
 
 
The causes of cerebral ischemia will be divided mainly  into  two categories. The 
one that cause Global ischemia and the others that cause ischemia of the focal 
area.Focal  ischemia results from a local disturbances in the vascular system. The 
aetiology of  the focal ischemia will be divided into three categories.
 (6)                  
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Primary diseases of the cerebral vasculature, embolism arising from the 
extracerebral areas and disorders of the haematological system.Vascular 
compromise is the ultimate common  pathway that results in inadequate supply of 
blood to a specific region in the brain, regardless of the aetiology. 
 (6) 
 
                                                         
        The alteration in the integrity of the endothelial wall initiate the formation of 
thrombus and it lead to disruption in the normal laminar blood flow. These changes 
will activate the coagulation cascade and subsequent thrombus production. The 
primary regulator of the thrombosis is thrombin, which activates the aggregation of 
the platelet and the formation of fibrin from the cleavage of the fibrinogen.
 (6) 
 
             This  fibrin then forms the clot matrix by crosslinkage.This thrombus either 
can block the vessel wall at the injured site of the endothelium or embolize distally 
by shear stress and the action of antithrombotic intrinsic  mechanism. 
            When the time progresses, these thromboemboli to the cerebral vasculature 
lyses spontaneously. Often  this will occur too late to prevent the formation of 
permanent infarction.Atherosclerosis is the most common cause for the focal 
ischemia formation. It is formed by the multifactorial process and lead to the 
formation of atheroma. 
(6) 
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      This atheroma contains cholesterol inflammatory cells, lipid laden 
macrophages,  
abnormally  proliferated endothelial smooth muscle cells and connective tissue 
forms within the vasculature. One of the key factors in the pathogenesis  of 
atherosclerosis is the injury of endothelium which causes the formation of fatty 
streak  and contributes to proliferation of smooth muscle cells. 
(6) 
The source of thrombi which occlude the small cerebral blood vessels is the 
thrombus that is formed at the site of atheromatous plaque. 
                                                        The factors which determines the formation of 
the atherosclerotic plaque will  produce the symptoms of ischemia. 
The basis for the atherosclerosis induced ischemia is the alteration in the local 
hemodynamic forces , luminal narrowing which exposes the thrombogenic contents 
of the necrotic core area. 
 
                      Atherosclerosis may has a predilection for the vessel wall bifurcation 
and curves in vasculature. In the cerebrovascular system, the atherosclerosis occurs 
commonly at the beginning of internal carotid  artery in neck area, distal  part of 
vertebral artery, carotid siphon and in the basilar artery. The prevalence of 
atherosclerosis increases when the age advances. It affects younger men when 
compared to women at younger age
.(6) 
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ATHEROSCLEROSIS RISK FACTORS: .( 8) 
 Old age 
 Family history of thrombotic stroke 
 Hypertension  
 Diabetes mellitus 
 Abnormal blood cholesterol level ( low HDL, High LDL) 
 Tobacco smoking  
                                                                    
PATHOPHYSIOLOGY: 
              
  Based on the previous discussion ischemia will be defined as an impairing tissue 
perfusion with a view to reduction in blood flow relative to the metabolic demand. 
Vessel occlusion produces a massive reduction in blood flow to the central core of 
the tissue and a less reduction in the surrounding zone.  
                              This surrounding tissue perfusion is maintained by the collateral 
circulation. There will be no change in brain metabolism as long as cerebral blood 
flow remains above 20 ml /100 gm / min .When the perfusion level reduces, the 
brain electrical activity fails and the neurological symptom arises. 
(6) 
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Since the oxygen supply becomes insufficient to maintain the normal cellular 
biochemical reaction, the high energy phosphate stores are quickly depleted. 
  
                                      Because of the meager supply of glucose to the tissue, 
anaerobic metabolism occurs which results in excessive lactate production. 
                   By the time the CBF is more severely reduced to 10-12 ml/100 gm/min 
, the cell membrane integrity is lost and the depolarization leads to efflux of 
potassium ions and influx of calcium ions into the neurons. This increased extra 
cellular calcium results in increased energy consumption and the activation of  the 
sodium-potassium  ATP -ase pump in an attempt to restore intracellular potassium. 
Because the increased demand of the substrate cannot be compensated by increases 
in CBF, ischemia results
.(6)
 
                                                               
CLINICAL FEATURES: 
                                     Vertebrobasilar system ischemia will produce motor  and  
sensory deficit. In addition to this, there will be a dysfunction of cranial nerve  or  
cerebellum. 
Small lesions of the brainstem produces unilateral isolated motor deficit. PCA 
involvement causes visual disturbances due to the ischemia of  Occipital lobe.  
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Ischemia of the terminal branches of the vertebral basilar branches to the 
cerebellum produces ataxia.
 (6) 
DEFINITION : 
TRANSIENT ISCHEMIC ATTACK: 
Abrupt loss of neurologic function occurred due to reduction in blood supply that 
persists for  < 24 hours and resolves without residual disability.
 .(6) 
ISCHEMIA : 
A constant supply of the oxygen and glucose will need for the brain‟s function 
which is supplied by cerebral blood vessel. Even though  the brain weighing 1 to 2 
percent   of the body weight, it receives the resting cardiac output of fifteen percent. 
It receives about 20 percent of  total oxygen consumption of our body. 
(6) 
   Because of the autoregulation of the cerebral vascular resistance, the cerebral 
blood flow remains constant over a broad range of blood pressure. 
                                                             
  Brain is an aerobic organ so that the other metabolic substrate use is limiting. The 
transient ischemia is due to interruption in the normal cerebral blood flow.  
                                  This cessation of blood flow will result from a reduction of 
perfusion pressure .Impaired tissue function caused by  reduction in blood supply  
and the metabolic demand.
( 3)
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DIAGNOSTIC STUDIES: 
         Diagnostic studies include neuroimaging techniques ,  and CSF analysis are  
very much useful. The neuroimaging findings of the cerebral ischemia will 
significantly vary with time. 
                              Within  twenty four hours of the onset of the symptoms, the CT 
Scan will detect  subtle signs of the infarction. The changes are blurring of the 
border between white and gray matter and loss of the sulci due to edema. 
 Magnetic resonance imaging of the brain is most sensitive to the ischemia.
 (6) 
TREATMENT: .
( 6)
 
 
                                            The aim of the treatment of the ischemic stroke is to 
limit the extent of the infarction and disability reduction. 
It can be achieved by 
 
I.  Augmentation of fibrinolysis ( thrombolytic  drugs) 
II. Salvation of neurons in the region of ischemic penumbra ( agents with 
neuroprotective property) 
III. To prevent the complication of stroke 
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The antiplatelet drugs and anticoagulant drugs role to prevent the progression of 
stroke is very much limited. The main goal of treatment in patients with ischemic 
stroke and the patients of  TIA is to minimize the risk of subsequent stroke. 
This is achieved through  
1. To reduce the thrombotic potential  by antiplatelet or the anticoagulant 
agents. 
2. Modification of risk factors. 
I . THROMBOLYTIC  AGENTS : 
Because the extent of brain injury which is induced by stroke is closely related to 
the severity and duration of ischemia, the clot lysing agents restore cerebrovascular 
perfusion eventually control the degree of injury. So that the outcome will improve 
by these agents. 
In acute ischemic stroke ,intravenous  streptokinase was tested. Because of the 
excessive haemorrhage, the trials were stopped. 
Tissue plasminogen activator was trialled and it was accepted  by the  United states 
Food and drug administration. tPA was associated with excellent recovery, 
provided when  it was administrated within first three hours of the onset of the 
symptoms. These  thrombolytic agents shall be injected directly into the occluded 
microthrombi by infusion through microcatheter . 
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It had the extensive advantage of higher recanalization rate and  safety 
improvement. The  drug dose requirement in this situation is very much lower. 
 
II. NEUROPROTECTIVE AGENTS: 
     The major goal of this therapy is to curtail  the cellular death in the region of 
ischemic penumbra. So that the size of the infarct will be limited and the outcome 
will be improved. 
Time is the important factor in efficient neuroprotective effect , since ischemia will 
irreversible within minutes to hours of the onset. 
Anticoagulant and  Antiplatelet  therapy: 
The role of aspirin in the treatment of acute stroke is limited. A randomized 
controlled  trial was conducted with aspirin which revealed a reduction in early 
mortality among the patients. Heparin has no consistent benefit in stroke patients. 
Even though  the risk of recurrent  stroke was reduced by heparin, it had the 
disadvantage  to increase the extra cranial haemorrhage and haemorrhagic stroke. 
III. PREVENTION OF THE COMPLICATIONS OF STROKE: 
They are the major cause of morbidity and mortality among the stroke patients. The 
most common complication is hypertension. 
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Primary and secondary prevention of stroke and TIA: 
                                                       
General principles: 
There are large number of strategies available to prevent the occurrence of stroke . 
They are medical therapies and surgical techniques  as well as modification of life 
style. 
Some of these techniques are applied in large extent on account of their low cost 
and with minimal risk. Others costs a lot of money and carry considerable risk but 
may be very useful  for high risk patients. Identification and prevention of the 
modifiable risk factors is the best way of planning  to minimize the burden of 
stroke.
 .(6)
 
   Hypertension is the most important risk factor. So all the hypertension must be      
treated. The  Statin drugs are used to reduce the risk of stroke in patients even 
without the elevated level of  cholesterol , which has confirmed by several trials. 
SPARCL:
 (8) 
(Stroke prevention by Aggressive reduction in cholesterol levels) 
It showed usefulness in secondary reduction in stroke for patients with TIA. 
Atorvastatin 80 mg/ day was prescribed for this patient.   Therefore statin must be 
prescribed in all patients with prior onset of  ischemic stroke.
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ANTIPLATELET AGENTS: .( 8) 
Atherothrombotic events like TIA and stroke can prevented by using 
antiaggregation  
agents by inhibit the formation of platelet aggregates in the intraarterial system. 
In the diseased artery  the platelet aggregates formed ,which either occlude the 
artery or lead to distal embolization. 
Agents to be used for this purpose are, 
Aspirin 
Clopidogrel 
Aspirin + Extended release Dipyridamole 
The most widely studied antiplatelet drug is aspirin.It activates the enzyme platelet 
cyclooxygenase, which inhibit the formation of Thromboxane A2 in platelets 
irreversibly.  It is a prostaglandin produced from the pathway  of cyclo-oxygenase 
with a property of  powerful  platelet  aggregation. 
This effect is permanent and its lasts for the life of the platelet. Aspirin also inhibit 
the production of Prostacyclin paradoxically. This Prostacyclin is an 
antiaggregating and vasodilating agents. When compared to aspirin, ticlopedine is 
more effective.
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This study was undertaken to identify the changes of electrophysiological  
parameters in VB TIA patients when compared to normal subjects.                                                      
The electrophysiological parameters used in this study were  VEP & BAEP. 
 The VEP represent the   mass response of the cortical and subcortical areas. 
If the entire visual system is intact,  then only the normal cortical responses are 
obtained and the abnormal VEP will be produced by the disturbances anywhere in 
the visual system . Because of this property, localizing  value of the VEP is 
limited
.(9)
 
                            VEP  is an  electrical response recorded from the visual cortex  
in response to a change in visual stimuli such as multiple flashes of light  ( Flash 
visual evoked potential). It can identify  the functional loss in the visual pathway 
from the visual cortex.  
The visual stimuli may be unstructured as in a flashing light,  or structured  ,as in 
some form of pattern to the flash stimuli or the stimuli may be patterned, as in 
checkerboard presented on a video display unit. The essential feature is that while 
the pattern changes, the overall illumination remain the same. Black squares go 
white and white become black and this will occur alternatively. The rate of the dark  
square become lightening  being the same as that of the darkening of the light 
squares
.(10) 
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FLASH VISUAL EVOKED RESPONSE: 
This is a most crude test and it indicates that light has been perceived. It is a fovea 
dominated response and is relatively unaffected by opacities in the cornea and the 
lens. It is therefore a useful test to grossly assess the intactness of the macula or the 
optic nerve. 
( 11)
 
                                                                
PATTERN REVERSAL VISUAL EVOKED RESPONSE : 
This depends on the form sense and may give a rough estimate of visual acuity. It is 
more of fovea specific  response .the timing of responses are more reliable than the 
amplitude. The preferred stimulus for the visual evoked potential testing is a 
checkerboard pattern of black and white squares
.(11) 
NORMAL VEP FINDINGS: 
The VEPs consists of a series of forms opposite polarity. The  negative waves are 
denoted by N and positive waves by P ,which is followed by the approximate 
latency in ms. The commonly seen wave forms are N75,P100,and N145. The peak 
latency and peak to peak amplitudes of these waves are measured.
 (9) 
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                             VISUAL EVOKED POTENTIAL: 
                                                     FIGURE:4 
 
 
 
 
 
 
 
 
 
BASIS OF VEP  ABNORMALITIES: 
The VEP abnormalities may be latency prolongation, amplitude reduction and 
combined latency and amplitude abnormalities. The commonest cause of prolonged 
P100 latency is demyelination in the optic pathways where the  
amplitude of P100 remains normal.
 (9) 
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CLINICAL USES OF VEP: 
The VEP study is a sensitive method for detecting the abnormalities in visual 
pathways especially anterior to the optic chiasma.It should be regarded as 
complementary to clinical examination and neuro-ophthalmological 
investigations.
(9)
 
CHECKER BOARD PATTERN OF VEP: 
 
                                    FIGURE:5 
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BRAINSTEM AUDITORY EVOKED POTENTIAL: 
Brainstem auditory evoked potentials (BAEP) are the potentials recorded from  
the ear by placing the electrodes in the scalp in response to a brief auditory 
stimulation to assess the conduction through the auditory pathway upto midbrain.  
The evoked potentials that appear following transduction of the acoustic stimulus 
by the ear cells create an electrical signal that is created through the auditory 
pathway to the brainstem and from there to the cerebral cortex. BAEPs comprise 
five or more waves within 10 ms of the stimulus. It may describe in terms of 
duration of onset of response.
  (12) 
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WAVE I – Cochlear nerve 
WAVE II – Cochlear nucleus 
WAVE III – Superior Olivary Nucleus 
WAVE IV – Lateral Lemniscus 
WAVE V – Inferior Colliculus 
 
 
                                         FIGURE:7 
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AUDITORY PATHWAY: 
             In human being the  sound reaches the brain through the ear. The frequency 
of sound that humans can hear ranges from 20 - 20,000 Hz. 
Then it travels through the outer, middle, and inner ear. In the Organ of  Corti  the 
mechanical sound waves are converted into electric neural signal.  
Then, the dendrites of primary auditory neurons communicate with these signal.  
Later they are bundled into cochlear nerve after which they join the vestibular 
nerve to form Vestibulo  cochlear nerve. Information is transferred through 
cochlear nuclei  reaches the Superior Olivary complex  and finally through the  
Inferior Colliculus , Lateral Lemniscus to the thalamus. At the level of cochlear 
nucleus this  sound waves  cross to the opposite  side. 
(13,14) 
                             The  Inferior Colliculus within the midbrain is divided into dorsal 
part nucleus and the central nucleus. The dorsal part receives both  somatosensory 
and auditory input. The central nucleus is involved in auditory localization. Within 
the thalamus, there is an oval structure found within diencephalon  which conveys 
sensory input to the Medial Geniculate Nucleus (MGN).As it act as a primary 
sensory area it represents a major relay station for auditory system. The Medial 
Geniculate Nucleus ( MGN)  consists of three subdivisions. Among  which, the 
principal nucleus receives the auditory input. 
(13,14) 
 
From  MGN, information is  relayed to the  primary auditory cortex  which is  
27 
                                   
otherwise called us A1.It is located on  transverse Gyrus of  Heschl situated within  
temporal lobe. This auditory cortical area allows the sensation of auditory 
characteristics like pitch. 
     This primary auditory cortex is composed of   many functional columns  
Neurons found within same column process sounds of the  same frequency. 
Further, they are tonotopically organized in similar to all the previous stages of 
auditory processing mentioned above.
 (15)
   
Auditory neurons are spatially arranged in an order– according to   auditory 
frequencies they process. There is more evidence that its distinction into two 
different pathways with peculiar functions  like in the visual cortex can  be found in 
auditory cortex. 
( 16 )
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                              VISUAL PATHWAY: 
 
 
 
 
                                                        FIGURE: 8 
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VISUAL PROCESSING AND VISUAL PATHWAY: 
 
 
 
                                                   FIGURE: 9 
 
The  ganglion cell‟s axon of the retina passes caudally in the optic nerve fibre and 
optic tract  which eventually  end in the lateral Geniculate body. The fibers from 
each nasal half of retina crosses  in the optic chiasm and leaves as optic tract 
whereas the temporal fibers will  not decussate.
(17)
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In the  lateral geniculate body, the nasal half of one retinal fibers  and the  other 
temporal half of the fibers synapse on the cells. The  axons of these geniculate 
bodies form the geniculocalcarine tract.This geniculocalcarine  tract passes to the  
occipital lobe of the cortex. Brodmann classify the visual cortex into 17,18 and 19. 
Brodmann‟s area 17is the primary visual cortex, Which is also known as V1.This 
primary visual cortex  is located principally in  the sides of the calcarine fissure . 
The organization of the primary visual cortex is summarized  in the following. 
Pretectal region of the midbrain  also receives Some of the axons  of ganglion 
cell.
(17)
   
                                BAEPs are much more useful to study in assess the objective 
function of the auditory system and also noninvasively. It specifically assess  the 
cochlea-auditory nerve – brainstem pathway resulting in an extensive development 
of  recording of both ear by placing the electrodes over the scalp and  the  far field  
electric potentials. 
EARLY AUDITORY EVOKED POTENTIALS: 
           Early auditory evoked potentials have also been reported to as short-latency 
auditory evoked potentials and corresponding to the responses recorded within the 
initial twelve  millisecond  after the given auditory stimulus. .
(18)
   
MIDDLE LATENCY AUDITORY EVOKED POTENTIALS: 
 Middle latency Auditory evoked potentials are potentials occurring between   
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12 and 50 msec  after an acoustic stimulation.. They  can be recorded from  
transient or from high frequency stimuli.  Middle latency Auditory evoked potential  
has been clinically  applied in the assessment of hearing threshold in infants and 
children, the identification of dysfunction in central auditory pathways, and the 
evaluation of the central auditory pathways in candidates for cochlear implants. .
(18)
   
LATE AUDITORY EVOKED POTENTIALS: 
Evoked potentials occurring  50 msec  after an acoustic stimulation are called slow 
or late auditory evoked potentials. These potentials can be subdivided into 
exogenous components.  N1,P1 and P2  which are primarily dependent on 
characteristics of the  
external stimulus ,and endogenous components such as P300,N400,CNV, 
and the mismatch negativity, which are more dependent on internal cognitive  
processes. 
(18) 
NORMAL BAEP  FINDINGS: 
  The BAEP consists of five or more distinct wave forms recorded within 10  
msec of the auditory stimulus and they are generated in different regions of the  
peripheral and central auditory pathways. Wave I is originated from the  
peripheral portion of the auditory system adjacent to  the Cochlea. 
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Wave II originates from the cochlear nucleus, wave III from the  
superior  olivary nucleus Wave IV  from the  Lateral lemniscus , and Wave V  
from inferior colliculi.
  
The Absolute Latencies and Interpeak latencies  I-III,III-V 
and ,I-V  were measured. Amplitude of Wave I and Wave V were measured. 
(18)
   
INTERPRETATION  OF BAEPS: 
BAEP interpretation requires identification and measurement of waves I,III,and V , 
the measurement of I-V and I-III intervals. These values could be compared with 
the normal values of the patients. 
                                First the absence of wave I with normal Wave V will probably 
reflects the technical problem in recording. Then absence of wave III is significant 
only when wave V is also missing or delayed. Finally BAEP s cannot be interpreted 
without considering the patients hearing status; conductive hearing loss and 
cochlear pathology may profoundly affect BAEP wave late latency and amplitude. 
.
(19)
   
 
FINDINGS OF EVOKED POTENTIALS IN VB TIA PATIENTS: 
Drake ME et al  Conducted a  study of  BAEP changes in vertebrobasilar transient 
ischemic attacks patients . The study  was recorded after resolution of symptoms ,  
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Some of the patient in this study  still had resolving  symptoms or signs. The 
findings  
in TIA patients were   longer I-III, III-V, and I-V interpeak latencies , but  these 
were not significant when compared to controls. Absolute latency of Wave V was 
significantly longer  and  amplitude of wave V is lower in TIA patients
.(4)  
P Benna et al conducted a study of brainstem evoked auditory response and visual 
evoked potentials of  pattern reversal  in patients suffering from vertebrobasilar 
TIA  
with a view  to obtain the  functions  of  cortical-subcortical areas.  BAEPs 
alterations occur in patients with  vertebrobasilar TIA .The parameters of  VEPs  
are normal in both group
.(5) 
Stewart A et al conducted  Brain-stem auditory evoked response (BAER) at about  
few days to two weeks  after a vertebrobasilar transient ischemic attack (VB TIA) . 
Initially  it  showed  absence of all waveforms, prolongation of  I –III , III –V and I-
V  inter-peak latencies and reduction of  amplitude . Some of the patients  showed 
reversal of  latencies and amplitude  to normal.  Normalization of the waves 
occurred 6 to 24 days after the VB TIA. The result  of this studies are different 
from  other reported  studies. 
(25) 
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               Factor S A et  al  studied Brain-stem auditory evoked response in   
vertebrobasilar transient ischemic attack (VB TIA)  patients . In the beginning , all 
showed, prolonged interpeak latencies, absence of waveforms  and reduction in 
amplitude . 5 out of 6 patients showed  reversal of the changes to normal.In rest of 
the  patients it   returned to near normal.  6 to 24 days after the VB TIA attack the 
results came to normal. These results are very much  different from other  reported  
studies
.(20)
 
Meier U
 
 et al   Studied  the value of  brain stem auditory evoked potentials in 
vertebrobasilar circulation to diagnose  the circulatory disorders. The evoked brain- 
stem potential in patients of  vertebrobasilar insufficiency showed variation in  
diagnostic evaluation in the literature. Their  examination revealed an advantage in 
subdividing  the BAEP changes into normal , slight and pronounced, within this  
group of patients of the  vertebrobasilar region blood supply disorders. Depending  
upon  the extent of the damage, the changes of  BAEP varied 
.(21)   
            Ferbert A et al studied  the  Evoked potentials in diagnosis of brain 
stem ischemia. They presented the  impact of evoked potentials in diagnosis of 
ischemic lesions of the  brainstem.  They found  Prolonged interpeak latency of 
Wave  I-III of  Brainstem auditory evoked potentials  in patients with caudal 
occlusions, whereas visual evoked potentials were  normal in most of the  cases.  
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The Brainstem Auditory  Evoked potential changes  are found  in patients with 
basilar artery thrombosis and primary  hemorrhage of the pontine area  indicating  
the location of the lesion. Further  they are of prognostic value. Depending  on the 
location of the infarction , the evoked potential changes  are found  in  basilar artery 
occlusive stroke
.(22) 
                                Thorwirth V et al studied the Brain stem Auditory evoked 
potentials and  visual pattern evoked  in transient ischemic attacks. Auditory-
evoked brainstem potentials, visual pattern-evoked and somatosensory-evoked 
potentials in transitory ischemic attacks (TIA).  They found that without any  
diagnostic risk , the  combination of visual evoked potentials and  auditory 
brainstem-evoked  can detect  the functional lesions in  regions of cerebrum with 
different blood flow . 
                                  Their results showed  that  there was a  delay in the  peak of 
Wave  III of the BAEP  in TIA in patients and  possibly of specific importance  in  
brainstem lesion
.(23)
 
 
 
Zhang X. J  et al  studied the Clinical Value of Brainstem Auditory Evoked 
Response  in the Diagnosis of Vertebrobasilar Ischemia. They found an abnormal 
value of BAEP in the patients of  vertebrobasilar ischemia (VBI). 
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BAEP is an easy and effective  means for the examination of VBI patients and  
providing objective evidence to diagnose  Vertebro basilar ischemia which  may 
be useful for  future  application
.(24) 
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MATERIALS  AND  
METHODS 
 
 
 
 
 
                                   
MATERIALS  AND  METHODS 
This study was conducted in the department of physiology, Thanjavur medical 
college & Hospital, Thanjavur. The study was case control type and  conducted 
between January 2015 and July 2015. The patients were selected from the  
department of  Internal medicine. 
In the 40 VB TIA Patients , 24 males and 16 females were selected in the age group 
of 50-70. VB TIA was confirmed by the Neuroimaging  technique  MRI . History 
of the patient was asked and complete examination including general and systemic 
examination was done. In the control group 23 males, 17 females of age group 50-
70 years were selected. 
Exclusion criteria : 
Neurological diseases 
Hearing defects 
Stroke  
Hypertension  
Diabetes mellitus 
Meniere 's disease 
Migraine 
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The Procedure  was explained to all the persons who were participated . Informed 
written consent was taken from both the controls  and subjects . The ethical 
committee was given an  approval to this study. 
The following electrophysiological parameters were studied: 
 Visual Evoked Potential (VEP) 
 Brainstem Auditory Evoked Potential ( BAEP ) 
All the parameters were recorded using  four channel Digital Polygraph. Digital 
Intex colour Monitor, 17” Model no : IT – 173 SB. 
      Medicaid neuroperfect plus Instrument  was used in this study . 
METHOD OF RECORDING VEP,BAEP: 
               Electrodes  were placed  using 10-20 electrode placement system.
(26) 
VISUAL EVOKED POTENTIAL: 
Pre test instructions:
(9)
 
1. The subject was explained about the procedure of this test . 
2. Informed consent were obtained. 
    3. The subject is instructed to avoid applying hair oil after  their last hair   Wash. 
    4. The subject can use their  Optical  lenses/Glasses during the test. 
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 5 .The subject is instructed not to use any mydriatics or miotics during the               
test. 
    6. Complete Ophthalmological examination was carried out to determine the  
visual acuity , field of vision. 
   7.The Room should be quite and comfortable. 
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RECORDING OF VEP: 
Settings for VEP: 
    
  SETTINGS  
 
    UNITS 
   Sweep  20 msec 
   Sensitivity  10 µV 
   Low cut 2 Hz 
   High cut 200 Hz 
 
   Pulse  1/sec 
   Pulse Width 0.1 msec 
   Notch  On 
   Recordings  100 average was recorded using Checker Board 
pattern stimulus 
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PROCEDURE: 
The  visual evoked potential which was tested by pattern reversal was measured 
separately   for both eyes by  the following steps, 
1.The skin is prepared by degreasing. 
2. The Recording electrode is  placed at Oz using Ten 20 CONDUCTIVE  
Neurodiagnostic electrode  Paste as per 10-20  international system of EEG  
electrode placement.
 (26) 
3.Reference electrode is placed at FPz. 
4. The Ground electrode is placed at Cz. 
5. The procedure is conducted in dark room with subject sitting at a distance of  
1 meter  from the VEP screen  which  is showing pattern reversal stimuli in 
Checker  board pattern with reversal rate 2/sec contrast 50-80% check size 28-32 of 
arc and number of trails is 100. 
6.Values are marked in the obtained waveform. 
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BRAINSTEM AUDITORY EVOKED POTENTIAL: 
Pre test instructions: 
(9) 
1.The Subject was explained about the procedure of the test.  
2.Informed consent was obtained from the subjects. 
3.  The subject is asked to avoid applying hair spray or hair oil after the last  
hair wash. 
4.Examination of the external ear was done & if any wax was found it was  
removed. 
4.Tunning fork test were carried out examples are Rinne‟s, Weber‟s & 
Absolute bone conduction test. 
5.Subject is made to relax completely. 
6.Room should be quite and comfortable. 
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RECORDING OF BAEP: 
Instrument settings for BAEP: 
 
SETTINGS 
 
BAEP 
Sweep 5 msec 
Sensitivity 10µV 
Low cut 100 Hz 
High cut 10 Hz 
Pulse 11/sec 
Pulse Width 0.1 msec 
Notch ON 
Decibels 60 Db 
Recordings 100 average was recorded using click 
sound as a stimuli 
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   PROCEDURE: 
    1.The skin is prepared by abrading and degreasing 
    2.The electrode is placed at  
                                  Channel 1 = Cz-Ai (ipsilateral ear) 
                                  Channel 2 = Cz – Ac ( contralateral ear) 
                                  Ground electrode is placed at 20% from the nasion Fz 
3. Head phones are placed on the ears for delivery of the auditory stimuli. 
Clicks are delivered at the rate of 8-10/sec.Intensity is to set at 60 db. About 
100 Averages are taken. 
    4.  Wave I to V are marked in the obtained wave form. Wave I is the first major      
upgoing peak following a stimuli. 
     5.Wave V is appear at approximately 6 ms and is often combined with wave IV 
into a single complex waveform. Wave III is the major peak between wave I and V. 
Wave II is typically the first major upward deflection in the Cz – Az waveform as 
Wave I is markedly attenuated or absent. 
 6. From the above wave form interpeak latency I-III, III-V , and I – V is obtained. 
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Statistical method:   
Electrophysiological parameters were analysed by using statistical package SPSS 
version 18 and statistical analysis was done by student  “ t ” test. 
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RESULTS 
 
 
 
 
 
 
                                   
RESULTS: 
In this study 80 subjects were included. 40  VB TIA patients were in study group 
and rest of the 40 normal subjects were in control group. 
In this study , 40 VB TIA study group were in the age of 50-70  years, mean  
58.725 ± 4.272   and control groups were in the age group of 50-70 years, mean 
58.975 ± 4.457. 
The two groups differ significantly in BAEP. P value was derived from data 
analysis using statistical package SPSS version and statistical analysis was done by 
student „t‟ test. The statistical significance was considered when P value  < 0.05 . 
. 
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                                   DESCRIPTIVE STATISTICS 
              TABLE 1: BAEP LATENCY   Findings –CONTROL (n = 40) 
LATENCY 
   (ms) 
SIDE MINIMUM MAXIMUM MEAN STANDARD 
DEVIATION 
WAVE  
I 
RIGHT 1.6 1.9 1.71575 0.075035 
LEFT 1.6 1.85 1.7125 0.064639 
WAVE 
 III 
RIGHT 3.55 4.08 3.776 0.105704 
LEFT 3.45 4 3.76275 0.101829 
WAVE  
V 
RIGHT 5.42 5.85 5.703 0.09962 
LEFT 5.42 6.02 5.74575 0.133607 
WAVE  
I-III 
RIGHT 1.85 2.46 2.06025 0.126054 
LEFT 1.6 2.3 2.05025 0.128731 
WAVE  
III-V 
RIGHT 1.57 2.25 1.927 0.154691 
LEFT 1.6 2.5 1.983 0.173104 
WAVE  
I-V 
RIGHT 3.7 4.2 3.98725 0.106962 
LEFT 3.67 4.27 4.03325 0.157046 
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          TABLE 2 : BAEP  LATENCY Findings –SUBJECT  (n = 40) 
LATENCY 
    (ms) 
SIDE MINIMUM MAXIMUM MEAN STANDARD 
DEVIATION 
WAVE  
I 
RIGHT 1.62 1.87 1.7295 0.057197 
LEFT 1.62 1.88 1.7275 0.076149 
WAVE 
 III 
RIGHT 3.6 4.02 3.77925 0.103686 
LEFT 3.62 3.98 3.78125 0.101633 
WAVE  
V 
RIGHT 5.42 6.08 5.74125 0.13915 
LEFT 5.52 5.98 5.7985 0.114635 
WAVE  
I-III 
RIGHT 1.81 2.3 2.04975 0.11652 
LEFT 1.85 2.33 2.06025 0.127192 
WAVE  
III-V 
RIGHT 1.58 2.4 1.962 0.187195 
LEFT 1.66 2.3 2.01725 0.162969 
WAVE  
I-V 
RIGHT 3.73 4.39 4.01175 0.137204 
LEFT 3.8 4.22 4.071 0.118013 
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                            TABLE 3 : BAEP Findings – P value 
LATENCY 
   (ms) 
SIDE CONTROL SUBJECT P-VALUE 
WAVE- I LEFT 1.7125 1.7275 0.18 
RIGHT 1.71575 1.7295 0.13 
WAVE-III LEFT 3.76275 3.78125 0.09 
RIGHT 3.776 3.77925 0.39 
WAVE-V LEFT 5.74575 5.7985 0.02 ** 
RIGHT 5.703 5.74125 0.04 ** 
WAVE I-
III 
LEFT 2.05025 2.05375 0.44 
RIGHT 2.06025 2.04975 0.25 
WAVE III-
V 
LEFT 1.983 2.01725 0.13 
RIGHT 1.927 1.962 0.11 
WAVE I-V LEFT 4.03325 4.071 0.09 
RIGHT 3.98725 4.01175 0.16 
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              TABLE 4 :BAEP  Amplitude  Findings – SUBJECT 
 
   
AMPLITUDE  
    (µV) 
 
SIDE 
 
MINIMUM 
 
MAXIMUM 
 
MEAN 
 
STANDARD 
DEVIATION 
WAVE  
    I 
RIGHT 3.02 22.15 9.972 5.401 
LEFT 3.58 13.42 8.3375 2.630 
WAVE 
   V 
RIGHT 8.01 31.64 17.146 6.971 
LEFT 8.28 37.84 17.449 6.882 
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                              TABLE 5 :BAEP  Findings – CONTROL 
 
   
AMPLITUDE 
     (µV) 
  
SIDE 
 
MINIMUM 
 
MAXIMUM 
 
MEAN 
 
STANDARD 
DEVIATION 
 
  WAVE  
     I 
 
RIGHT 
 
3.31 
 
15.64 
 
9.482 
 
3.61 
 
LEFT 
 
4.12 
 
18.26 
 
8.978 
 
3.619 
   
   WAVE 
    V 
 
RIGHT 
 
7.05 
 
42.31 
 
20.498 
 
9.359 
 
LEFT 
 
8.75 
 
36.58 
 
19.95 
 
5.670 
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                        TABLE 6 :BAEP  Findings – „P‟ Value 
 
   
AMPLITUDE(µV) 
 
SIDE 
 
SUBJECT 
 
CONTROL 
   P 
VALUE 
 
     WAVE  
          I 
 
RIGHT 
 
9.972 
 
9.482 
 
0.32 
 
LEFT 
 
8.337 
 
8.978 
 
 
0.19 
 
     WAVE 
         V 
 
RIGHT 
 
17.146 
 
20.498 
 
0.05 ** 
 
LEFT 
 
17.449 
 
19.95 
 
0.04 ** 
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TABLE 7 :VISUAL EVOKED POTENTIAL – CONTROL    (n=40) 
 
LATENCY(ms
) 
 
SIDE 
 
MINIMU
M 
 
MAXIMU
M 
 
MEAN 
STANDAR
D 
DEVIATIO
N 
 
   N75 
RIGH
T 
69 78.5 73.262
5 
2.081628 
LEFT 69.5 80 73.237
5 
2.345174 
 
    P100 
RIGH
T 
95 108 100.51
2 
2.8227 
LEFT 91.5 117.5 101.68
7 
4.8047 
 
     N145 
RIGH
T 
139 152 145.48
7 
2.9515 
LEFT 138 151 143.63
7 
3.2679 
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         TABLE 8 :VISUAL EVOKED POTENTIAL – SUBJECT  (n = 40) 
 
 
 
LATENCY(ms) 
 
SIDE 
 
MINIMUM 
 
MAXIMUM 
 
MEAN 
STANDARD 
DEVIATION 
 
    N75 
RIGHT 70 77 73.037 1.677 
LEFT 69.5 78 72.95 2.0933 
    
    P100 
RIGHT 97 105 100.775 1.822 
LEFT 95 115 101.812 3.553 
 
    N145 
RIGHT 138.5 152 145.475 2.832 
LEFT 137.5 149.5 144.1 2.539 
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          TABLE 9 :   VISUAL EVOKED POTENTIAL – P VALUE  
 
LATENCY(ms) 
 
SIDE 
 
SUBJECT 
 
CONTROL 
 
    P VALUE 
 
    N75 
RIGHT 73.037 73.2625 0.21 
LEFT 72.95 73.2375 0.14 
    
    P100 
RIGHT 100.775 100.512 0.22 
LEFT 101.812 101.687 0.38 
 
    N145 
RIGHT 145.475 145.487 0.44 
LEFT 144.1 143.637 0.07 
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      TABLE 10 : VISUAL EVOKED POTENTIAL - 
CONTROL   
   
AMPLITUDE     
(µV) 
 
SIDE 
 
MINIMUM 
 
MAXIMUM 
 
MEAN 
 
STANDARD 
DEVIATION 
 
 P 100 
 
RIGHT 
 
3.02 
 
22.15 
 
11.433 
 
1.919383 
 
LEFT 
 
3.58 
 
13.42 
 
11.358 
 
2.221044 
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      TABLE 11 : VISUAL EVOKED POTENTIAL - SUBJECT  
 
   
AMPLITUDE(µV) 
 
SIDE 
 
MINIMUM 
 
MAXIMUM 
 
MEAN 
 
STANDARD 
DEVIATION 
 
 P 100 
 
RIGHT 
 
3.02 
 
22.15 
 
11.477 
 
1.834364 
 
LEFT 
 
3.58 
 
13.42 
 
11.345 
 
2.142257 
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       TABLE 12 :  VISUAL EVOKED POTENTIAL - P VALUE 
 
   
AMPLITUDE 
    (µV) 
 
SIDE 
 
CONTROL 
 
SUBJECT 
 
P VALUE 
 
 
    P 100 
 
RIGHT 
 
11.433 
 
11.477 
 
0.12 
 
LEFT 
 
11.358 
 
11.345 
 
0.4 
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                                          FIGURE:10 
                        
 The Absolute Latency of  Wave I of left side in VB TIA patients show the mean 
value of   1.7275±0.076149   and in the control group it is   1.7125±0.064639  with 
a P value of  0.18  showing the difference insignificant. 
 
The Absolute Latency of  Wave I of right side inVB TIA  patients show the mean 
value of  1.7295±0.057197   and in the control group it is 1.71575±0.075035  with 
a P value of 0.13  showing the difference insignificant. 
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                                           FIGURE:11 
 
The Absolute Latency of  Wave III  of left side in VB TIA patients show the mean 
value of   3.78125±0.101633    and in the control group it is   3.76275±0.101829  
with a P value of 0.09  showing the difference insignificant. 
The Absolute Latency of  Wave III of right side in VB TIA  patients show the mean 
value of  3.77925±0.103686   and in the control group it is 3.776±0.105704  with a 
P value of 0.39  showing the difference insignificant. 
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                                            FIGURE:12 
The Absolute Latency of  Wave V of left side in VB TIA patients show the mean 
value of   5.7985±0.114635  and in the control group it is   5.74575±0.133607  with 
a P value of 0.02   showing the difference significant. 
 
The Absolute Latency of  Wave V of right side in VB TIA  patients show the mean 
value of  5.74125±0.13915   and in the control group it is 5.703±0.09962 with a P 
value of 0.04 showing the difference significant. 
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                                             FIGURE:13 
 
Interpeak latency Wave I-III of left side in VB TIA patients show the mean value 
of  2.06025 ±0.127192  and in the control group it is 2.05025 ±0.128731   with a P 
value of  0.44  showing the difference insignificant. 
 
Interpeak latency Wave I-III  of right side in VB TIA  patients show the mean value 
of 2.04975 ± 0.11652  and in the control group it is 2.06025 ± 0.126054  with a P 
value of  0.25  showing the difference insignificant. 
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                                             FIGURE:14 
Interpeak latency Wave III - V of left side in VB TIA patients show the mean value 
of 2.01725 ± 0.162969    and in the control group it is 1.983±0.173104     with a P 
value of   0.13     showing the difference insignificant. 
 
Interpeak latency Wave III - V  of right side in VB TIA  patients show the mean 
value of 1.962 ± 0.187195     and in the control group it is  1.927±0.154691     with 
a P value of   0.11     showing the difference insignificant 
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                                            FIGURE:15 
 
Interpeak latency Wave I-V of left side in VB TIA patients show the mean value of  
4.071 ± 0.118013   and in the control group it is 4.03325  ± 0.157046    with a P 
value of  0.09      showing the difference insignificant. 
 
Interpeak latency Wave I-V  of right side in VB TIA  patients show the mean value 
of 4.01175 ± 0.137204    and in the control group it is 3.98725 ± 0.106962           
with a P value of 0.16        showing the difference insignificant 
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                                            FIGURE:16 
              Amplitude of  Wave I of left side in VB TIA patients show the mean value 
of  8.3375±2.630  and in the control group it is 8.978±3.619   with a P value of  
0.19 showing the difference insignificant. 
 
                     Amplitude of  Wave I of right  side in VB TIA patients show the mean 
value of  9.972±5.401   and in the control group it is 9.482±3.61   with a P value of  
0.32  showing the difference insignificant. 
                      
                   Amplitude of  Wave V of left side in VB TIA patients show the mean 
value of  17.449±6.882  and in the control group it is 19.95±5.67   with a P value of  
0.04 showing the difference significant. 
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                    Amplitude of  Wave V of  right side in VB TIA patients show the 
mean value of  17.146±6.971  and in the control group it is 20.498±9.359   with a P 
value of  0.05  showing the difference significant. 
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                                      FIGURE:17 
 VISUAL EVOKED POTENTIALS: 
The Absolute Latency of  N 75 of left side in VB TIA patients show the mean value 
of  72.95±2.0933  and in the control group it is 73.2375± 2.345174   with a P value 
of  0.14  showing the difference insignificant. 
 
The Absolute Latency of  N 75 of left side in VB TIA patients show the mean value 
of  73.037±1.677  and in the control group it is 73.2625±2.081628   with a P value 
of  0.21  showing the difference insignificant. 
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                                             FIGURE:18 
VISUAL EVOKED POTENTIALS: 
The Absolute Latency of  P 100  of left side in VB TIA patients show the mean 
value of  101.812 ± 3.553  and in the control group it is 101.687±4.8047  with a P 
value of  0.38  showing the difference insignificant. 
 
The Absolute Latency of  P 100  of Right  side in VB TIA patients show the mean 
value of  100.775±1.822  and in the control group it is 100.512±2.8227  with a P 
value of  0.22  showing the difference insignificant 
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                                             FIGURE:19 
VISUAL EVOKED POTENTIALS: 
The Absolute Latency of  N 145  of left side in VB TIA patients show the mean 
value of 144.1± 2.539   and in the control group it is 143.637±3.2679   with a P 
value of  0.07  showing the difference insignificant 
 
The Absolute Latency of  N 145  of Right  side in VB TIA patients show the mean 
value of 145.475 ± 2.832  and in the control group it is 145.487± 2.9515    with a P 
value of  0.44  showing the difference insignificant 
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                                      FIGURE:20 
VISUAL EVOKED POTENTIALS: 
Amplitude of P 100 of left side in VB TIA patients show the mean value of   
11.345  ± 2.142257  and in the control group it is 11.358±2.221044     with a P 
value of  0.19 showing the difference insignificant. 
 
Amplitude of  P 100 of right  side in VB TIA patients show the mean value of 
11.477 ± 1.834364  and in the control group it is 11.433±  1.919383      with a P 
value of  0.32  showing the difference insignificant. 
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DISCUSSION: 
In this study, the electrophysiological parameters were evaluated in patients with 
VB TIA. The results of the electrophysiological study were compared between 40 
patients with VB TIA and 40 healthy subjects. 
In this study, the Absolute Latency of Wave V is prolonged  and reduction in 
Amplitude of  Wave V  in patients with VB TIA and is found to be statistically 
significant. It  suggested that the diminished blood flow and alteration in cerebral 
metabolism during the course of transient ischemic attack may be the possible 
explanation for the amplitude reduction of BAEP. The amplitude depends on the 
intactness of the blood flow which is essential for  the function of the brain. 
In this study, no changes were found  in the Interpeak latency of brainstem auditory 
evoked potential I-III,III-V ,and I-V in patients with VB TIA  and statistically it 
was not significant. 
This study showed that the symptoms relating to the VB TIA may be due to the 
reduction in blood flow to the brain especially the cerebellar cortex. 
In the present study , empathized  with the study of  Benna P et al showed no 
changes were observed  in the  VEP parameters N75,  P100 & N145.Similar 
Results were observed by Benna P et al.
 (5) 
Stroke is an important consequence of VB TIA . TIA is a chronic process , in this  
 
72 
                                   
disease there will be a formation of atherosclerotic plaque. The symptoms are 
mainly due to the formation of emboli which may originate from other systemic 
organs. The resolution of symptom is due to collateral formation or lysis of emboli. 
                 However the clinical observation and neuroimaging suggested that TIA 
had a deleterious effect and it will further lead to the development of stroke. Since 
the electrophysiological studies are useful  to identify the changes in VB TIA 
patients, we could prevent them to develop the full blown stroke. 
             Measurement of stimulus conduction by means of evoked potentials is 
sensitive and reliable in the earlier detection of subclinical changes. 
                This study results are consistent with DRAKE ME et al, PENNA B et al 
showed significant reduction in amplitude of  wave V and normal parameters of 
VEP  suggested that there has been a reduction in blood flow in posterior 
circulation. In this study, there was a reduction in amplitude of wave V and 
Prolongation of Absolute Latency  of Wave V  of BERA in patients with VB TIA 
and it was statistically significant (P Value < 0.05) . These patients had  a 
subclinical changes in vessel wall so that the blood flow was reduced.
 (4,5) 
               Mills JA et al   evaluated brainstem auditory evoked potential in patients of 
reduced cerebral blood circulation and found that a significant change in  absolute 
latency of wave V( P <0.05). and it was concluded that there is an alteration in 
myelination. 
 (37)
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                                                Rossi L et al evaluated brainstem auditory evoked 
potential in VB TIA patients. They found a significant change in  prolongation in 
Wave V latency  (P< 0.05) and it was concluded that there is an alteration in 
myelination in VB TIA patients.
 (41)
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  CONCLUSION 
 
       Electrophysiological parameter like absolute latency of  I,III,V and interpeak 
latencies of I-III,  III-V, I-V  , amplitude  of  wave I & V  were evaluated. In the 
present Study , Amplitude reduction in Wave V  and  prolongation of Latency of  
Wave V of BERA were observed. 
 In VEP, No changes were observed in Latency and Amplitude. This study is very 
much useful  to identify the early detection of progression of stroke in VB TIA   
Patients. 
Finally further studies are required to evaluate the correlation between the 
electrophysiological parameters & progression into stroke . So that preventive 
measures can be used to prevent early involvement of Stroke. 
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ABBREVIATIONS USED IN THE STUDY 
 
TIA –  TRANSIENT ISCHEMIC ATTACK 
VB TIA – VERTEBROBASILAR TRANSIENT ISCHEMIC ATTACK 
BAEP  -- BRAINSTEM AUDITORY EVOKED POTENTIAL 
VEP – VISUAL EVOKED POTENTIAL 
PCA –POSTERIAR CEREBRAL ARTERY 
CSF – CEREBROSPINAL FLUID 
HDL – HIGH DENSITY LIPOPROTEIN 
LDL – LOW DENSITY LIPOPROTEIN 
CBF – CEREBRAL BLOOD FLOW 
MGN – MEDIAL GENICULATE NUCLEUS 
 
 
 
 
 
 
                                   
INFORMED CONSENT FORM 
  Dr.R.Mohan, Post graduate student in the Department of physiology, Thanjavur 
Medical college, Thanjavur is studying the “CHANGES OF AUDITORY 
EVOKED POTENTIAL AND VISUAL EVOKED POTENTIAL IN 
VERTEBROBASILAR TRANSIENT ISCHEMIC ATTACKS PATIENTS ” 
 
                   I understand the procedure and voluntarily agree to participate in the 
study, I also understand that this study is a non-invasive procedure and the possible 
adverse effects have been explained to me in details clearly in my own language. 
                                                        
                                                                               Signature of the subject 
                
       Name: 
       Place: 
       Date:  
                                        
 
 
 
                                   
PROFORMA 
TOPIC:  “CHANGES OF AUDITORY EVOKED POTENTIAL AND 
VISUAL EVOKED POTENTIAL IN VERTEBROBASILAR TRANSIENT 
ISCHEMIC ATTACKS PATIENTS” 
 
Study group/Control group 
 
Name:                                             Age:                               Sex: 
Address:                                       Occupation: 
                                                        
H/O of Presenting  illness:   
                                           H/o Giddiness 
Past history: Known case of DM/SHT/PULMONARY TB/ASTHMA 
Personal history: Smoking/alcohol/betalnut chewing with or without tobacco 
General Examination: 
Height:                                                                    Weight                                       
Anaemic / Not anaemic   
Cyanosis / No cyanosis 
Clubbing / No Clubbing 
                                   
Jaundice / No jaundice 
Pedal oedema / No pedal oedema 
Generalised lymphadenopathy present/Absent 
Vital Signs:          PR:                            BP:                            RR: 
Examination of CVS:  
Examination of RS: 
Examination of Abdomen: 
Examination of CNS: 
Investigations: 
 BRAINSTEM AUDITORY  EVOKED RESPONSE 
 
 WAVE 
LATENCY           
(ms) 
 
    I 
 
  III 
 
    V 
 
 I-III IPL 
 
 III-V 
IPL 
 
 I-V IPL 
 
 RIGHT 
      
 
 LEFT 
      
 
 
                                   
    
     AMPLITUDE (µV) 
 
                    I 
 
                   V 
      
        RIGHT 
  
         
         LEFT 
  
 
VISUAL EVOKED POTENTIAL RESPONSE 
 
 
LATENCY(ms) 
 
N 75 
 
P 100 
 
N 145 
 
RIGHT 
   
 
LEFT 
   
 
 
 
 
 
                                   
 
AMPLITUDE   P 100 (µV) 
 
 
RIGHT EYE 
 
 
LEFT EYE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                   
 
 
 
 
 
 
 
 
 
 
 
 
MASTER CHART 
 
 
 
 
                                   
  BERA 
LATENCYCONTROL 
      (ms) 
                    BERA 
AMPLITUDE 
(µV)  
    
S. NO AGE / 
SEX 
     I L C  I R C  III L C   III R 
C 
 V L C  V R C  I - III 
L C 
  I - 
III R 
C 
 III - V 
L C 
  III - 
V R C 
   I - V 
L C 
   I - V 
R C 
AMP 
I L C 
  AMP 
V L C 
AMP I 
R C 
AMP V 
R C 
1 55/F 1.68 1.65 3.7 3.65 5.5 5.6 2.02 2 1.8 1.95 3.82 3.95 11.21 16.52 7.24 15.31 
2 56/M 1.7 1.65 3.85 3.82 5.68 5.42 2.15 2.17 1.83 1.6 3.98 3.77 5.31 18.51 6.34 32.12 
3 54/M 1.7 1.65 3.68 3.88 5.72 5.68 1.98 2.23 2.04 1.8 4.02 4.03 8.12 24.31 14.51 8.43 
4 67/M 1.72 1.72 3.72 3.92 5.78 5.72 2 2.2 2.06 1.8 4.06 4 9.34 15.32 15.28 24.15 
5 62/F 1.62 1.72 3.62 3.78 5.8 5.72 2 2.06 2.18 1.94 4.18 4 10.15 9.15 7.34 9.61 
6 64/M 1.7 1.72 3.9 3.78 5.6 5.78 2.2 2.06 1.7 2 3.9 4.06 8.64 12.36 6.21 27.02 
7 62/M 1.65 1.7 3.72 3.85 5.78 5.65 2.07 2.15 2.06 1.8 4.13 3.95 7.15 22.35 8.31 16.05 
8 56/F 1.62 1.65 3.75 3.88 5.72 5.7 2.13 2.23 1.97 1.82 4.1 4.05 7.75 15.42 15.64 27.46 
9 58/M 1.68 1.68 3.68 3.95 5.56 5.6 2 2.27 1.88 1.65 3.88 3.92 14.13 25.34 14.96 12.01 
10 58/M 1.75 1.65 3.9 3.75 5.6 5.7 2.15 2.1 1.7 1.95 3.85 4.05 5.31 17.32 8.12 9.12 
11 54/M 1.8 1.72 3.82 3.62 5.75 5.82 2.02 1.9 1.93 2.2 3.95 4.1 6.16 23.05 15.21 35.08 
12 52/F 1.72 1.82 3.72 3.82 5.88 5.7 2 2 2.16 1.88 4.16 3.88 9.23 24.15 15.62 15.15 
13 51/F 1.65 1.65 3.75 3.78 5.7 5.48 2.1 2.13 1.95 1.7 4.05 3.83 9.12 18.43 15.36 32.15 
14 56/M 1.82 1.75 3.65 3.72 5.65 5.7 1.83 1.97 2 1.98 3.83 3.95 9.52 25.56 8.75 18.31 
15 68/F 1.75 1.7 3.75 3.75 5.88 5.68 2 2.05 2.13 1.93 4.13 3.98 11.25 8.75 8.87 8.16 
16 62/F 1.82 1.62 3.72 3.8 5.6 5.82 1.9 2.18 1.88 2.02 3.78 4.2 9.72 22.15 5.64 27.16 
17 60/M 1.78 1.75 3.72 3.7 5.7 5.78 1.94 1.95 1.98 2.08 3.92 4.03 8.35 20.45 3.31 15.01 
18 57/F 1.65 1.78 3.65 3.65 5.82 5.78 2 1.87 2.17 2.13 4.17 4 9.65 15.62 5.57 8.32 
19 54/F 1.78 1.62 3.8 3.62 5.78 5.7 2.02 2 1.98 2.08 4 4.08 4.87 13.48 7.34 20.05 
20 53/M 1.68 1.65 3.98 3.7 5.95 5.78 2.3 2.05 1.97 2.08 4.27 4.13 8.43 15.38 9.02 22.86 
 
                                   
 
 
 
S. NO AGE / 
SEX 
    I L C  I R C  III L C   III R C  V L C  V R C  I - III 
L C 
  I - III 
R C 
 III - 
V L C 
  III - 
V R C 
   I - V 
L C 
  I - V 
R C 
AMP 
I L C 
  AMP 
V L C 
AMP I 
R C 
AMP V 
R C 
21 57/F 1.78 1.72 3.68 3.85 5.6 5.6 1.9 2.13 1.92 1.75 3.82 3.88 14.15 18.54 5.45 32.12 
22 62/M 1.72 1.65 3.78 3.85 5.82 5.85 2.06 2.2 2.04 2 4.1 4.2 5.67 27.32 8.06 35.21 
23 64/F 1.7 1.78 3.8 3.78 5.78 5.8 2.1 2 1.98 2.02 4.08 4.02 5.32 18.43 8.45 17.36 
24 63/M 1.68 1.7 3.78 3.68 5.42 5.78 2.1 1.98 1.64 2.1 3.74 4.08 4.76 24.51 10.13 34.42 
25 64/F 1.65 1.75 3.78 3.75 5.75 5.75 2.13 2 1.97 2 4.1 4 5.16 36.58 7.34 42.31 
26 56/M 1.8 1.9 3.68 3.75 5.75 5.7 1.88 1.85 2.07 1.95 3.95 3.8 13.32 28.47 8.03 14.52 
27 54/M 1.75 1.85 3.78 3.75 5.7 5.78 2.03 1.9 1.92 2.03 3.95 3.93 4.12 21.42 6.31 25.61 
28 58/M 1.78 1.7 3.85 3.55 5.72 5.8 2.07 1.85 1.87 2.25 3.94 4.1 8.57 18.53 5.24 16.21 
29 67/F 1.65 1.75 3.78 3.7 5.85 5.72 2.13 1.95 2.07 2.02 4.2 3.97 7.32 22.27 4.58 23.24 
30 62/M 1.78 1.62 3.88 4.08 5.45 5.7 2.1 2.46 1.57 1.62 3.67 4.08 16.24 17.42 12.13 12.01 
31 61/F 1.75 1.62 3.75 3.75 6.02 5.75 2 2.13 2.27 2 4.27 4.13 12.54 19.31 15.62 9.61 
32 64/M 1.85 1.8 3.45 3.9 5.95 5.78 1.6 2.1 2.5 1.88 4.1 3.98 5.21 16.51 9.43 7.05 
33 61/F 1.6 1.8 3.78 3.9 5.85 5.8 2.18 2.1 2.07 1.9 4.25 4 15.24 23.54 13.23 25.43 
34 59/F 1.7 1.8 3.9 3.78 5.8 5.7 2.2 1.98 1.9 1.92 4.1 3.9 18.26 18.54 10.08 16.54 
35 60/M 1.62 1.85 3.68 3.85 5.88 5.8 2.06 2 2.2 1.95 4.26 3.95 7.53 24.51 12.13 8.35 
36 64/M 1.7 1.72 3.68 3.8 5.8 5.65 1.98 2.08 2.12 1.85 4.1 3.93 5.72 17.45 8.57 14.53 
37 58/M 1.75 1.8 3.75 3.75 5.72 5.7 2 1.95 1.97 1.95 3.97 3.9 6.42 17.45 5.61 25.24 
38 57/M 1.65 1.6 3.85 3.58 5.92 5.6 2.2 1.98 2.07 2.02 4.27 4 15.12 16.31 12.31 18.75 
39 52/F 1.62 1.75 3.8 3.85 5.75 5.45 2.18 2.1 1.95 1.6 4.13 3.7 4.51 15.12 9.43 25.75 
40 57/M 1.7 1.62 4 3.72 5.85 5.6 2.3 2.1 1.85 1.88 4.15 3.98 10.54 32.15 8.54 32.13 
                                   
VEP LATENCY (ms) 
  
  
      VEP AMPLITUDE 
(µv) 
CONTROL           CONTROL   
     N75 L    N75 R   P 100 L    P 100 
R 
   N 145 L    N 145 
R 
AMP - P100 
L 
AMP - 
P100 R 
74 75 97 95 145 142.5 10.32 13.8 
76.5 77 91.5 100 138 146 12.58 13.75 
70.5 71 101 100 146 145 12.89 12.72 
71.5 74 94.5 101 138 146.5 13.65 13.87 
71 74.5 101 95 145 146 11.72 12.65 
71.5 70.5 101.5 102.5 138.5 145.5 13.21 13.56 
72.5 75 104.5 106 146 148.5 7.48 12.83 
72.5 73 99.5 104.5 146 148.5 12.47 7.65 
76.5 72.5 101.5 103 147 149 8.36 8.52 
74.5 74.5 100.5 102.5 138.5 144 13.45 9.52 
70.5 74 99.5 100.5 145 152 9.46 11.34 
73 71 103.5 102 145 148.5 12.84 12.67 
75.5 75.5 100 100.5 141 145.5 13.83 8.32 
76.5 76.5 102 101 138 147 9.85 9.76 
73 72.5 99.5 105.5 146.5 144 14.23 14.02 
72.5 73 105.5 99.5 145.5 145 12.64 12.37 
71.5 73.5 98.5 98 148 142 14.06 12.42 
70 73.5 103.5 102 141 145.5 13.5 9.42 
70.5 73 99 98 144 151.5 12.01 10.46 
78.5 73 100.5 
 
101 151 141.5 7.01 12.54 
                                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
70.5 73.5 105 101 144 147.5 8.01 11.37 
70 72.5 101.5 101 142.5 147.5 9.28 10.14 
73.5 71 101 100 146 146.5 9.6 8.5 
73 71.5 101 100 144 144.5 12.97 11.92 
71.5 71 103.5 100 146 145 9.51 10.18 
80 72.5 115.5 100 138.5 145 7.7 8.2 
73 77 97.5 98 143 145 11.56 12.58 
73.5 70 98 102.5 144 141.5 8.44 14.02 
73.5 75 106.5 104.5 142.5 144 13.22 11.49 
74.5 74 102 100 144 144.5 12.37 12.67 
75 75.5 117.5 99.5 146.5 141.5 13.2 13.28 
74.5 74 108.5 108 138 147 12.18 12.11 
73.5 73.5 102 98 142.5 139 13.14 9.58 
69.5 70.5 97.5 101.5 148 144 8.23 13 
75 78.5 96.5 98 144 141 12.31 13.18 
74.5 69 103 96.5 143 148 12.96 8.58 
74 71 99.5 102 148.5 146 13.05 9.56 
72 73.5 102 97 144 148 13.15 12.08 
71.5 73 98 98.5 141 140 10.45 12.92 
74.5 71.5 107.5 97 142.5 150 7.45 9.78 
                                   
BERA LATENCY 
   SUBJECT(ms) 
                            BERA AMPLITUDE   
        SUBJECT(µV) 
  
S.N
O 
AGE / 
SEX 
I L  I R  III L  III R  V L  V R  I - III L  I - III R  III - V L  III - V R  I - V L  I - V R   I L    V L    I R   V R  
1 55/M 1.78 1.62 3.82 3.72 5.85 5.68 2.04 2.1 2.03 1.96 4.07 4.06 7.26 9.35 12.13 15.64 
2 64/F 1.62 1.76 3.88 3.88 5.82 5.52 2.26 2.12 1.94 1.64 4.2 3.76 5.28 12.53 8.26 23.52 
3 56/M 1.72 1.72 3.65 4.02 5.92 5.78 1.93 2.3 2.27 1.76 4.2 4.06 8.26 13.54 10.15 15.34 
4 63/M 1.7 1.74 3.85 3.88 5.92 5.85 2.15 2.14 2.07 1.97 4.22 4.11 4.24 25.34 5.13 25.06 
5 66/M 1.62 1.68 3.65 3.62 5.72 5.78 2.03 1.94 2.07 2.16 4.1 4.1 6.21 9.21 12.23 19.35 
6 62/F 1.62 1.68 3.82 3.88 5.52 5.55 2.2 2.2 1.7 1.67 3.9 3.87 10.42 15.21 6.54 22.01 
7 59/M 1.78 1.67 3.68 3.78 5.98 5.52 1.9 2.11 2.3 1.74 4.2 3.85 12.51 25.31 8.32 8.31 
8 57/F 1.72 1.7 3.72 3.82 5.55 5.75 2 2.12 1.83 1.93 3.83 4.05 8.71 26.34 15.34 8.62 
9 55/F 1.75 1.72 3.68 3.92 5.78 5.65 1.93 2.2 2.1 1.73 4.03 3.93 9.34 15.61 7.18 11.42 
10 56/M 1.62 1.76 3.92 3.72 5.7 5.75 2.3 1.96 1.78 2.03 4.08 3.99 8.36 18.31 3.26 13.52 
11 58/M 1.7 1.87 3.92 3.68 5.58 5.74 2.22 1.81 1.66 2.06 3.88 3.87 10.51 12.61 5.54 9.65 
12 54/F 1.82 1.76 3.78 3.8 5.62 5.75 1.96 2.04 1.84 1.95 3.8 3.99 13.42 8.61 12.21 15.34 
13 56/M 1.7 1.69 3.68 3.82 5.92 5.42 1.98 2.13 2.24 1.6 4.22 3.73 8.36 14.51 6.12 9.34 
14 64/F 1.78 1.78 3.78 3.75 5.62 5.8 2 1.97 1.84 2.05 3.84 4.02 7.34 8.31 4.15 15.16 
15 63/M 1.75 1.82 3.7 3.68 5.92 6.02 1.95 1.86 2.22 2.34 4.17 4.2 3.58 14.61 15.42 18.26 
16 62/M 1.8 1.76 3.98 4.02 5.72 5.6 2.18 2.26 1.74 1.58 3.92 3.84 5.21 26.35 12.51 14.52 
17 59/F 1.68 1.8 3.65 3.65 5.78 5.72 1.97 1.85 2.13 2.07 4.1 3.92 7.34 18.54 7.45 11.31 
18 54/M 1.72 1.7 3.78 3.6 5.88 5.65 2.06 1.9 2.1 2.05 4.16 3.95 5.87 15.61 5.62 12.62 
19 55/M 1.65 1.65 3.72 3.7 5.8 5.58 2.07 2.05 2.08 1.88 4.15 3.93 5.24 12.34 5.31 25.21 
20 59/F 1.62 1.72 3.88 3.65 5.75 5.82 2.26 1.93 1.87 2.17 4.13 4.1 12.31 15.61 12.32 8.34 
 
                                   
 
21 52/ F 1.72 1.68 3.72 3.78 5.85 5.78 2 2.1 2.13 2 4.13 4.1 5.34 8.28 15.32 22.52 
22 57/ M 1.75 1.64 3.82 3.78 5.7 5.75 2.07 2.14 1.88 1.97 395 4.11 9.65 14.51 10.15 9.35 
23 69/ F 1.62 1.72 3.75 3.82 5.8 5.82 2.13 2.1 2.05 2 4.18 4.1 5.34 12.31 8.56 27.56 
24 61/M 1.65 1.65 3.65 3.7 5.72 5.72 2 2.05 2.07 2.02 4.07 4.07 11.21 8.58 14.51 19.68 
25 67/M 1.78 1.69 3.75 3.68 5.92 6.08 1.97 1.99 2.17 2.4 4.14 4.39 9.65 15.37 3.25 8.01 
26 62/F 1.72 1.82 3.82 3.8 5.82 5.82 2.1 1.98 2 2.02 4.1 4 12.34 15.61 22.15 13.45 
27 53/M 1.68 1.79 3.78 3.82 5.85 5.72 2.1 2.03 2.07 1.9 4.17 3.93 12.23 18.34 6.45 28.35 
28 52/M 1.88 1.76 3.82 3.65 5.72 5.65 1.94 1.89 1.9 2 3.84 3.89 7.46 18.57 14.45 16.35 
29 57/F 1.62 1.64 3.85 3.82 5.82 5.78 2.23 2.18 1.97 1.96 4.2 4.14 6.78 20.15 8.75 9.35 
30 58/M 1.72 1.75 3.92 3.98 5.8 5.72 2.2 2.23 1.88 1.74 4.08 3.97 6.31 12.54 19.02 21.03 
31 60/M 1.62 1.7 3.95 3.75 5.72 5.62 2.33 2.05 1.77 1.87 4.1 3.92 12.57 20.51 3.02 27.35 
32 60/F 1.7 1.72 3.62 3.88 5.78 5.72 1.92 2.16 2.16 1.84 4.08 4 8.63 24.57 21.24 16.34 
33 61/F 1.82 1.78 3.75 3.88 5.88 6.05 1.93 2.1 2.13 2.17 4.06 4.27 8.35 16.95 9.16 14.65 
34 55/M 1.85 1.72 3.92 3.75 5.92 5.98 2.07 2.03 2 2.23 4.07 4.26 7.75 18.54 16.21 31.64 
35 54/M 1.78 1.76 3.65 3.82 5.78 5.82 1.87 2.06 2.13 2 4 4.06 5.89 18.42 5.46 14.53 
36 53/F 1.8 1.68 3.65 3.75 5.88 5.65 1.85 2.07 2.23 1.9 4.08 3.97 6.73 32.41 3.14 30.05 
37 61/M 1.75 1.75 3.78 3.72 5.92 5.72 2.03 1.97 2.14 2 4.17 3.97 10.65 12.65 21.36 14.51 
38 59/M 1.82 1.75 3.78 3.65 5.88 5.85 1.96 1.9 2.1 2.2 4.06 4.1 8.12 26.43 12.54 31.23 
39 57/M 1.85 1.83 3.75 3.8 5.85 5.65 1.9 1.97 2.1 1.85 4 3.82 6.53 37.84 5.94 12.15 
40 64/F 1.82 1.75 3.98 3.75 5.98 5.82 2.16 2 2 2.07 4.16 4.07 12.21 27.56 3.02 15.21 
 
 
 
                                   
VEP LATENCY 
        (ms) 
  
        VEP AMPLITUDE 
(µV)  
SUBJECT           SUBJECT   
N75L N75R P100L P100R N145L N145R AMP-P100 
L 
AMP-P100 
R 
75.5 74.5 99.5 97.5 145.5 142 11.32 13.58 
75 75 95 99.5 145 145.5 12.64 13.5 
69.5 72.5 96.5 97 145.5 145 13.02 12.5 
71 75.5 98.5 102 137.5 147 13.45 13.5 
71.5 72.5 99.5 100.5 145 145 12.05 12.5 
72 72.5 100 100 145 145 13.45 13.84 
74 74 102.5 104.5 145.5 147.5 7.58 13 
74 72.5 102 102 146 148 11.87 8.02 
75.5 70 103.5 102 145.5 148.5 8.4 8.34 
71 72.5 99.5 100.5 144 144.5 12.85 9.46 
72 72 102 99.5 145 152 9.2 11.5 
71 70.5 102 102.5 145.5 148 12.5 12.5 
77 74 103.5 99.5 141.5 145 13.5 8.5 
75 75 103.5 103 142 147.5 9.5 9.5 
72.5 70.5 102 102 145.5 144 14 13.85 
70 71 102.5 100.5 145 145 12.5 12.5 
70 71.5 100 99.5 147.5 143 13.89 12.05 
72 74 100 101.5 141 145 13.45 9.84 
73.5 72.5 100.5 99.5 144.5 151 12.45 10.5 
75.5 75.5 102 102.5 149.5 141 7.05 12.58 
 
                                   
69.5 75 104.5 102.5 143.5 148 8.05 11.45 
72.5 73.5 100 98.5 142.5 147.5 9.5 10.35 
72 70.5 102.5 99 145.5 146.5 9.5 9 
71.5 72.5 100 101.5 145 145 12.5 12.05 
73 73 102.5 102 145.5 145 9.45 10.42 
78 74.5 107.5 102.5 138.5 145 7.5 8.45 
74.5 74.5 102.5 100 142.5 144.5 11.26 12.85 
75 72.5 100 103 145 141 8.5 13.85 
72 72.5 105 101.5 145 145.5 13.02 12 
72.5 72 100.5 98.5 144.5 145 12.5 12.5 
74.5 77 115 97 145.5 142 13 13.2 
74 72.5 110.5 105 138.5 147.5 12.45 12.5 
75 71.5 100 100.5 141.5 138.5 13.25 9.75 
70 72 100 102 148 145 8.5 13.05 
72.5 75 98.5 100.5 143.5 142 12.5 13.5 
73 70.5 103.5 100 143 148.5 12.5 8.45 
72.5 73 97.5 101 148 145.5 13.1 9.75 
70 75 103.5 100 143.5 147.5 13.2 11.85 
73.5 74.5 99.5 101 141.5 140.5 11.02 12.76 
75 72 105 99.5 142 149.5 7.85 9.82 
 
 
